thymidine has been researched along with Local Neoplasm Recurrence in 37 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the usefulness of 3'-deoxy-3'-[18F]fluorothymidine (FLT)-positron emission tomography (PET) for predicting response and patient outcome of gefitinib therapy in patients with adenocarcinoma of the lung." | 7.74 | [18F]Fluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma of the lung. ( Im, KC; Kim, SW; Lee, DH; Lee, JS; Moon, DH; Oh, SJ; Ryu, JS; Sohn, HJ; Suh, C; Yang, YJ, 2008) |
| " This study examines the predictive value of positron emission tomography (PET) using [18F] fluorothymidine (FLT), an imaging biomarker of cell proliferation, in patients with recurrent malignant gliomas treated with bevacizumab in combination with irinotecan." | 7.74 | Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study. ( Chen, W; Cloughesy, T; Czernin, J; Delaloye, S; Geist, C; Lai, A; Phelps, ME; Pope, W; Satyamurthy, N; Sayre, J; Silverman, DH, 2007) |
| "The present retrospective study aims to determine the clinical value of thymidine labelling index (TLI) together with other established clinical and biological factors in 116 locally advanced breast cancer (LABC) patients treated with anthracycline-based neoadjuvant chemotherapy, surgery, adjuvant chemotherapy and radiotherapy." | 7.71 | Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome. ( Aydiner, A; Bilir, A; Bozfakioglu, Y; Cabioglu, N; Dagoglu, T; Dolay, K; Igci, A; Kecer, M; Muslumanoglu, M; Ozmen, V, 2001) |
| "From 1982 to 1992, DNA synthesis was assessed by [3H]thymidine incorporation in 97 samples of primary lesions from 94 patients with breast cancer." | 7.70 | In vitro DNA synthesis in freshly separated human breast cancer cells assessed by tritiated thymidine incorporation assay: relationship to the long-term outcome of patients. ( Inamoto, T; Kan, N; Kodama, H; Nio, Y; Ohgaki, K; Tamura, K, 1999) |
| "We have approached the question of the reliability of the thymidine labeling index (TLI) of breast carcinoma by comparing paired samples." | 7.67 | Reliability and stability of the thymidine labeling index of breast carcinoma. ( McDivitt, RW; Meyer, JS, 1986) |
| "The in vitro Thymidine Labelling Index (TLI) of 164 primary breast carcinoma was measured." | 7.67 | In vitro thymidine labelling index in primary operable breast cancer. ( Cooke, TG; Croton, R; George, WD; Holt, S; Leinster, SJ; McDicken, I; Nicholson, RI, 1986) |
| "To evaluate the usefulness of 3'-deoxy-3'-[18F]fluorothymidine (FLT)-positron emission tomography (PET) for predicting response and patient outcome of gefitinib therapy in patients with adenocarcinoma of the lung." | 3.74 | [18F]Fluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma of the lung. ( Im, KC; Kim, SW; Lee, DH; Lee, JS; Moon, DH; Oh, SJ; Ryu, JS; Sohn, HJ; Suh, C; Yang, YJ, 2008) |
| " This study examines the predictive value of positron emission tomography (PET) using [18F] fluorothymidine (FLT), an imaging biomarker of cell proliferation, in patients with recurrent malignant gliomas treated with bevacizumab in combination with irinotecan." | 3.74 | Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study. ( Chen, W; Cloughesy, T; Czernin, J; Delaloye, S; Geist, C; Lai, A; Phelps, ME; Pope, W; Satyamurthy, N; Sayre, J; Silverman, DH, 2007) |
| "The present retrospective study aims to determine the clinical value of thymidine labelling index (TLI) together with other established clinical and biological factors in 116 locally advanced breast cancer (LABC) patients treated with anthracycline-based neoadjuvant chemotherapy, surgery, adjuvant chemotherapy and radiotherapy." | 3.71 | Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome. ( Aydiner, A; Bilir, A; Bozfakioglu, Y; Cabioglu, N; Dagoglu, T; Dolay, K; Igci, A; Kecer, M; Muslumanoglu, M; Ozmen, V, 2001) |
| "From 1982 to 1992, DNA synthesis was assessed by [3H]thymidine incorporation in 97 samples of primary lesions from 94 patients with breast cancer." | 3.70 | In vitro DNA synthesis in freshly separated human breast cancer cells assessed by tritiated thymidine incorporation assay: relationship to the long-term outcome of patients. ( Inamoto, T; Kan, N; Kodama, H; Nio, Y; Ohgaki, K; Tamura, K, 1999) |
| "The relationship of changes in 3H-thymidine labelling index (TLI) induced by primary chemotherapy to tumor response and relapse rate in 36 patients with previously untreated locally advanced breast cancer (LABC) was analyzed." | 3.69 | Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer. ( Alama, A; Camoriano, A; Campora, E; Gardin, G; Meazza, R; Merlini, L; Naso, C; Pronzato, P; Repetto, L; Rosso, R, 1994) |
| "Proliferative activity, evaluated as [3H]thymidine labelling index ([3H]dT LI), and hormone receptors were determined on 97 primary breast cancers and on metachronous lesions from the same patient." | 3.68 | Biological characterisation of primary and metachronous lesions in breast cancer patients. ( Coradini, D; Daidone, MG; Di Fronzo, G; Salvadori, B; Silvestrini, R; Valentinis, B, 1992) |
| "We have approached the question of the reliability of the thymidine labeling index (TLI) of breast carcinoma by comparing paired samples." | 3.67 | Reliability and stability of the thymidine labeling index of breast carcinoma. ( McDivitt, RW; Meyer, JS, 1986) |
| "The in vitro Thymidine Labelling Index (TLI) of 164 primary breast carcinoma was measured." | 3.67 | In vitro thymidine labelling index in primary operable breast cancer. ( Cooke, TG; Croton, R; George, WD; Holt, S; Leinster, SJ; McDicken, I; Nicholson, RI, 1986) |
| "The in vitro effects of cortisol, estradiol, progesterone, and testosterone on the uptake of tritiated thymidine into the tumor cells of 25 women with primary or metastatic breast cancer were studied and compared with the objective clinical response to ablative endocrine surgery." | 3.65 | In vitro assay for human breast cancer hormone responsiveness. A study of 25 cases with clinical correlation. ( Burstein, NA; Carey, RW, 1974) |
| "Prostate cancer is an androgen-dependent disease; metastatic prostate cancer is typically treated by androgen receptor (AR) blockade." | 1.33 | Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. ( Agoulnik, IU; Alvarado, M; Ayala, GE; Bingman, WE; Erdem, H; Frolov, A; Ittmann, MM; Nakka, M; Smith, CL; Vaid, A; Weigel, NL, 2006) |
| "Primary tumours and metastases of the same patient frequently showed different sensitivity." | 1.25 | [In-vitro testing of the sensitivity of mammary carcinoma cells to cytostatic drugs (author's transl)]. ( Bastert, G; Gerner, R; Leppien, G; Michel, RT; Nord, D; Schmidt-Matthiesen, H, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (51.35) | 18.7374 |
| 1990's | 12 (32.43) | 18.2507 |
| 2000's | 6 (16.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sohn, HJ | 1 |
| Yang, YJ | 1 |
| Ryu, JS | 1 |
| Oh, SJ | 1 |
| Im, KC | 1 |
| Moon, DH | 1 |
| Lee, DH | 1 |
| Suh, C | 1 |
| Lee, JS | 1 |
| Kim, SW | 1 |
| Agoulnik, IU | 1 |
| Vaid, A | 1 |
| Nakka, M | 1 |
| Alvarado, M | 1 |
| Bingman, WE | 1 |
| Erdem, H | 1 |
| Frolov, A | 1 |
| Smith, CL | 1 |
| Ayala, GE | 1 |
| Ittmann, MM | 1 |
| Weigel, NL | 1 |
| Chen, W | 1 |
| Delaloye, S | 1 |
| Silverman, DH | 1 |
| Geist, C | 1 |
| Czernin, J | 1 |
| Sayre, J | 1 |
| Satyamurthy, N | 1 |
| Pope, W | 1 |
| Lai, A | 1 |
| Phelps, ME | 1 |
| Cloughesy, T | 1 |
| Tubiana, M | 1 |
| Pejovic, MH | 1 |
| Chavaudra, N | 1 |
| Contesso, G | 1 |
| Malaise, EP | 1 |
| Cooke, T | 1 |
| George, WD | 2 |
| Griffiths, K | 1 |
| Gardin, G | 1 |
| Alama, A | 1 |
| Rosso, R | 1 |
| Campora, E | 1 |
| Repetto, L | 1 |
| Pronzato, P | 1 |
| Merlini, L | 1 |
| Naso, C | 1 |
| Camoriano, A | 1 |
| Meazza, R | 1 |
| Bisail, M | 1 |
| Nieddu, S | 1 |
| Sarobba, MG | 1 |
| Sanna, G | 1 |
| Milia, V | 1 |
| Ghì, MG | 1 |
| Farris, A | 1 |
| Vander Borght, T | 1 |
| Pauwels, S | 1 |
| Lambotte, L | 1 |
| Labar, D | 1 |
| De Maeght, S | 1 |
| Stroobandt, G | 1 |
| Laterre, C | 1 |
| Alberts, DS | 1 |
| Einspahr, J | 1 |
| Ritenbaugh, C | 1 |
| Aickin, M | 1 |
| Rees-McGee, S | 1 |
| Atwood, J | 1 |
| Emerson, S | 1 |
| Mason-Liddil, N | 1 |
| Bettinger, L | 1 |
| Patel, J | 1 |
| Bellapravalu, S | 1 |
| Ramanujam, PS | 1 |
| Phelps, J | 1 |
| Clark, L | 1 |
| Abubakar, AA | 1 |
| Riches, AC | 1 |
| Katayama, N | 1 |
| Kita, K | 1 |
| Kawakami, K | 1 |
| Mitani, H | 1 |
| Sugawara, T | 1 |
| Mizuno, S | 1 |
| Yonezawa, A | 1 |
| Nishii, K | 1 |
| Miwa, H | 1 |
| Wada, H | 1 |
| Minami, N | 1 |
| Shiku, H | 1 |
| Ottaviani, G | 1 |
| Lavezzi, AM | 1 |
| De Ruberto, F | 1 |
| Fichera, G | 1 |
| Matturri, L | 1 |
| De Reuck, J | 1 |
| Santens, P | 1 |
| Goethals, P | 1 |
| Strijckmans, K | 1 |
| Lemahieu, I | 1 |
| Boon, P | 1 |
| Achten, E | 1 |
| Lemmerling, M | 1 |
| Vandekerckhove, T | 1 |
| Caemaert, J | 1 |
| Senekowitsch-Schmidtke, R | 1 |
| Rüth, F | 1 |
| Bernatz, S | 1 |
| Nio, Y | 1 |
| Tamura, K | 1 |
| Kan, N | 1 |
| Inamoto, T | 1 |
| Ohgaki, K | 1 |
| Kodama, H | 1 |
| Ozmen, V | 1 |
| Cabioglu, N | 1 |
| Dolay, K | 1 |
| Bilir, A | 1 |
| Kecer, M | 1 |
| Aydiner, A | 1 |
| Muslumanoglu, M | 1 |
| Igci, A | 1 |
| Bozfakioglu, Y | 1 |
| Dagoglu, T | 1 |
| Shibuya, TY | 1 |
| Nugyen, N | 1 |
| McLaren, CE | 1 |
| Li, KT | 1 |
| Wei, WZ | 1 |
| Kim, S | 1 |
| Yoo, GH | 1 |
| Rogowski, A | 1 |
| Ensley, J | 1 |
| Sakr, W | 1 |
| Frankel, AE | 1 |
| Powell, BL | 1 |
| Hall, PD | 1 |
| Case, LD | 1 |
| Kreitman, RJ | 1 |
| Bastert, G | 1 |
| Schmidt-Matthiesen, H | 1 |
| Gerner, R | 1 |
| Michel, RT | 1 |
| Nord, D | 1 |
| Leppien, G | 1 |
| Silvestrini, R | 1 |
| Valentinis, B | 1 |
| Daidone, MG | 1 |
| Di Fronzo, G | 1 |
| Coradini, D | 1 |
| Salvadori, B | 1 |
| Awwad, HK | 1 |
| Khafagy, Y | 1 |
| Barsoum, M | 1 |
| Ezzat, S | 1 |
| el-Attar, I | 1 |
| Farag, H | 1 |
| Akoush, H | 1 |
| Meabid, H | 1 |
| Zaghloul, MS | 1 |
| McGuire, Wl | 2 |
| Meyer, JS | 2 |
| Barlogie, B | 1 |
| Kute, TE | 1 |
| Fowble, B | 1 |
| Karak, AK | 1 |
| Mathur, M | 1 |
| Choudhry, VP | 1 |
| Dressler, LG | 1 |
| McDivitt, RW | 1 |
| Holt, S | 1 |
| Croton, R | 1 |
| Leinster, SJ | 1 |
| McDicken, I | 1 |
| Nicholson, RI | 1 |
| Cooke, TG | 1 |
| Hoshino, T | 1 |
| Kobayashi, S | 1 |
| Townsend, JJ | 1 |
| Wilson, CB | 1 |
| Punnonen, R | 1 |
| Rantanen, J | 1 |
| Grönroos, M | 1 |
| Hoge, AF | 1 |
| Hartsuck, JM | 1 |
| Kollmorgen, GM | 1 |
| Schilling, JA | 1 |
| Ziegler, JL | 1 |
| Bluming, AZ | 1 |
| Fass, L | 1 |
| Morrow, RH | 1 |
| Iversen, OH | 1 |
| Burstein, NA | 1 |
| Carey, RW | 1 |
| McCredie, JA | 1 |
| Inch, WR | 1 |
| Sutherland, RM | 1 |
| Lord, IJ | 1 |
| Bryce, DP | 1 |
| McClure, JA | 1 |
| Briant, TD | 1 |
| van Nostrand, P | 1 |
| Whittaker, MG | 1 |
| Clark, CG | 1 |
| Terz, JJ | 1 |
| Curutchet, HP | 1 |
| Lawrence, W | 1 |
| Burns, ER | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Could Positon Emission Tomography With Radiolabelled 3'-Deoxy-3'-(18)F-Fluoro-L-Thymidine be a Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patients ?[NCT02069418] | Phase 2 | 80 participants (Anticipated) | Interventional | 2014-02-28 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for thymidine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Intraductal noninvasive breast cancer: a comparison of three local treatments.
Topics: Breast Neoplasms; Carcinoma in Situ; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Ther | 1989 |
3 trials available for thymidine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps.
Topics: Adenomatous Polyps; Aged; Calcium Carbonate; Calcium, Dietary; Cell Division; Cells, Cultured; Colon | 1997 |
Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Aspartate Aminotran | 2002 |
Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cell Division; Combined Modality Therapy; Female; Head and Ne | 1992 |
33 other studies available for thymidine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
[18F]Fluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Fluorine Radioisotope | 2008 |
Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.
Topics: Androgens; Cell Line, Tumor; Cell Proliferation; Exons; Humans; Immunohistochemistry; Introns; Male; | 2006 |
Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chem | 2007 |
The long-term prognostic significance of the thymidine labelling index in breast cancer.
Topics: Autoradiography; Axilla; Breast Neoplasms; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; | 1984 |
Possible test for selection of adjuvant systemic therapy in early cancer of the breast.
Topics: Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Mitotic Index; Neoplasm Recurrence, Local; R | 1980 |
Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Chemot | 1994 |
[The labelling index as a prognostic marker in breast carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Autoradiography; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Duc | 1994 |
Brain tumor imaging with PET and 2-[carbon-11]thymidine.
Topics: Adolescent; Adult; Aged; Brain; Carbon Radioisotopes; Child; Deoxyglucose; Female; Fluorodeoxyglucos | 1994 |
A possible correlation between growth-factor sensitivity and response to mitoxantrone treatment in a murine myeloid leukaemia (SA7HD) cell line.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Cell Count; Cell Division; Culture Media, Conditioned; | 1997 |
Granulocyte colony-stimulating factor and its receptor in acute promyelocytic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorescent Antibody Technique; Granu | 1998 |
The prognostic value of cell proliferation in colorectal adenomas assessed with tritiated thymidine and anti-proliferating cell nuclear antigen.
Topics: Adenomatous Polyps; Adult; Aged; Aged, 80 and over; Autoradiography; Cell Division; Colonoscopy; Col | 1999 |
[Methyl-11C]thymidine positron emission tomography in tumoral and non-tumoral cerebral lesions.
Topics: Adolescent; Adult; Aged; Astrocytoma; Blood-Brain Barrier; Brain Diseases; Brain Neoplasms; Carbon R | 1999 |
Radiolabeled thymidine: a sensitive tracer for early tumor response and recurrence after irradiation.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Colonic Neoplasms; Humans; Mice; Mice, Nude; Neoplas | 1999 |
In vitro DNA synthesis in freshly separated human breast cancer cells assessed by tritiated thymidine incorporation assay: relationship to the long-term outcome of patients.
Topics: Analysis of Variance; Breast Neoplasms; DNA, Neoplasm; Female; Follow-Up Studies; Humans; Middle Age | 1999 |
Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Axilla; Breast Neoplasms; DNA, Neop | 2001 |
Clinical significance of poor CD3 response in head and neck cancer.
Topics: Carcinoma, Squamous Cell; CD3 Complex; Disease-Free Survival; Female; Head and Neck Neoplasms; Human | 2002 |
[In-vitro testing of the sensitivity of mammary carcinoma cells to cytostatic drugs (author's transl)].
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cyclophosphamide; Female; Humans; In Vitro T | 1975 |
Biological characterisation of primary and metachronous lesions in breast cancer patients.
Topics: Breast Neoplasms; Cell Division; Female; Humans; Mitosis; Neoplasm Metastasis; Neoplasm Recurrence, | 1992 |
Impact of flow cytometry on predicting recurrence and survival in breast cancer patients.
Topics: Analysis of Variance; Aneuploidy; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Small Cell; Cell C | 1985 |
Tritiated thymidine labeling index in Indian childhood acute lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Cell Count; Child; Child, Preschool; Female; Humans; Infant; Leukemia, Ly | 1987 |
Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients.
Topics: Breast Neoplasms; Cell Cycle; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Humans; Neoplasm | 1985 |
Reliability and stability of the thymidine labeling index of breast carcinoma.
Topics: Biopsy; Breast Neoplasms; Carcinoma; Humans; Mastectomy; Mathematics; Neoplasm Recurrence, Local; Ne | 1986 |
In vitro thymidine labelling index in primary operable breast cancer.
Topics: Autoradiography; Breast Neoplasms; Carcinoma; DNA, Neoplasm; Female; Follow-Up Studies; Humans; Mast | 1986 |
A cell kinetic study on medulloblastomas.
Topics: Adolescent; Adult; Autoradiography; Biopsy; Cell Cycle; Cell Division; Cerebellar Neoplasms; Child; | 1985 |
Effects of bleomycin on 3H-thymidine incorporation in the skin and on the DNA, RNA and ATP syntheses in the primary tumour of patients with vulval carcinoma.
Topics: Adenosine Triphosphate; Aged; Bleomycin; Depression, Chemical; DNA, Neoplasm; Female; Humans; Middle | 1974 |
Endocrine and immunologic studies in breast cancer.
Topics: Adrenalectomy; Adult; Binding, Competitive; Breast Neoplasms; Castration; Drug Hypersensitivity; Est | 1973 |
Burkitt's lymphoma: cell kinetics, treatment and immunology.
Topics: Antibodies, Neoplasm; Antibodies, Viral; Burkitt Lymphoma; Culture Techniques; Cyclophosphamide; Cyt | 1973 |
In vitro assay for human breast cancer hormone responsiveness. A study of 25 cases with clinical correlation.
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Adult; Aged; Animals; Breast Neoplasms; Carcinoma; Carcin | 1974 |
Peripheral blood lymphocytes and breast cancer.
Topics: Adult; Age Factors; Breast Neoplasms; Carcinoma; Female; Humans; Leukocyte Count; Lymphocyte Activat | 1973 |
Hyperbaric perfusion of the isolated larynx. An autoradiographic study.
Topics: Aged; Animals; Autoradiography; Carcinoma, Squamous Cell; Cell Survival; DNA; Dogs; Female; Histolog | 1971 |
Depressed lymphocyte function in carcinoma of the breast.
Topics: Breast Neoplasms; Female; Humans; Lectins; Lymphocyte Activation; Lymphocytes; Neoplasm Recurrence, | 1971 |
Analysis of the cell kinetics of human solid tumors.
Topics: Adult; Aged; Biopsy; Bone Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Division; Colo | 1971 |
Initiation of DNA synthesis in Ehrlich ascites tumor cells in their plateau phase of growth.
Topics: Amino Acids; Animals; Ascitic Fluid; Autoradiography; Carcinoma, Ehrlich Tumor; Clone Cells; DNA Rep | 1968 |